22q11.2 deletion syndrome.
McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, Scambler PJ, Bassett AS.
Nat Rev Dis Primers. 2015 Nov 19;1:15071. doi: 10.1038/nrdp.2015.71.
Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
McDonald-McGinn DM, Sullivan KE.
Medicine (Baltimore). 2011 Jan;90(1):1-18. doi: 10.1097/MD.0b013e3182060469.
Clinical Manifestations of 22q11.2 Deletion Syndrome.
Cirillo A, Lioncino M, Maratea A, Passariello A, Fusco A, Fratta F, Monda E, Caiazza M, Signore G, Esposito A, Baban A, Versacci P, Putotto C, Marino B, Pignata C, Cirillo E, Giardino G, Sarubbi B, Limongelli G, Russo MG.
Heart Fail Clin. 2022 Jan;18(1):155-164. doi: 10.1016/j.hfc.2021.07.009. Epub 2021 Oct 25.
Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and Management.
Biggs SE, Gilchrist B, May KR.
Curr Allergy Asthma Rep. 2023 Apr;23(4):213-222. doi: 10.1007/s11882-023-01071-4. Epub 2023 Mar 10.
DiGeorge syndrome: consider the diagnosis.
Altshuler E, Saidi A, Budd J.
BMJ Case Rep. 2022 Feb 2;15(2):e245164. doi: 10.1136/bcr-2021-245164.
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML.
J Clin Immunol. 2023 Feb;43(2):247-270. doi: 10.1007/s10875-022-01418-y. Epub 2023 Jan 17.
[Di George syndrome].
Urrejola P, Cattani A, Heusser F, Talesnik E.
Rev Chil Pediatr. 1991 Nov-Dec;62(6):381-5.
Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders.
Shin D, Kim CN, Ross J, Hennick KM, Wu SR, Paranjape N, Leonard R, Wang JC, Keefe MG, Pavlovic BJ, Donohue KC, Moreau C, Wigdor EM, Larson HH, Allen DE, Cadwell CR, Bhaduri A, Popova G, Bearden CE, Pollen AA, Jacquemont S, Sanders SJ, Haussler D, Wiita AP, Frost NA, Sohal VS, Nowakowski TJ.
Cell Stem Cell. 2024 Mar 7;31(3):421-432.e8. doi: 10.1016/j.stem.2024.01.010. Epub 2024 Feb 20.
Neurological manifestation of 22q11.2 deletion syndrome.
Bayat M, Bayat A.
Neurol Sci. 2022 Mar;43(3):1695-1700. doi: 10.1007/s10072-021-05825-8. Epub 2022 Jan 18.
Antipsychotic Treatment of 22q11.2 Deletion Syndrome-Related Psychoses.
Angelopoulos E, Theleritis C, Economou M, Georgatou K, Papageorgiou CC, Tsaltas E.
Pharmacopsychiatry. 2017 Jul;50(4):162-163. doi: 10.1055/s-0043-109559. Epub 2017 May 16.
